Profile
INM VRTX REGN ALNY SGEN ARGX
Company Name InMed Pharmaceuticals Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.30M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.01K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Eric A. Adams Chem., M.I.B. Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
INM VRTX REGN ALNY SGEN ARGX
Quant Rating Score 3 2 4 1 3 2
Quant Rating Neutral Sell Buy Strong Sell Neutral Sell
Trading
INM VRTX REGN ALNY SGEN ARGX
Last Close $2.78 $464.2 $547.96 $311.12 $228.74 $555.96
High 52 $5.5 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.12 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -49.45 % -10.17 % -54.4 % -6.26 % 0 % -17.24 %
Price vs. 52 Week Low 2216.67 % 17.03 % 13.47 % 38.53 % 0 % 20.6 %
Total Return
INM VRTX REGN ALNY SGEN ARGX
1 Month Return 17.3 % 2.95 % 4.84 % 0.76 % 0 % 0.86 %
3 Month Return 4.16 % -4.46 % -0.24 % 34.98 % 0 % -5.38 %
6 Month Return -38.22 % 11.33 % -20.96 % 24.87 % 0 % -15.74 %
9 Month Return 1020.97 % -6.92 % -45.11 % 4.84 % 0 % 2.23 %
YTD Return -41.35 % 15.27 % -23.07 % 32.22 % 0 % -9.6 %
1 Year Return 941.2 % -5.07 % -49.96 % 24.53 % 0 % 17.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
INM VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -841060.93 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
INM VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM -267.35 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -68.71 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -192.89 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -56.66 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 135.67 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 111.47 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -177.46 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -1863.47 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 6.46 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM 10.72 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 154.48 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 25.6 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -713.01 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -713.02 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 43070.48 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -328.91 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -1863.47 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM - -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM - -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM - -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
INM VRTX REGN ALNY SGEN ARGX
Revenue $0.01B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 23.94% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -10.07 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
INM VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.01B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.04B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
INM VRTX REGN ALNY SGEN ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.76
AARD Aardvark Therapeutics, Inc. Common Stock 11.61
ABCL AbCellera Biologics Inc. 3.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.95
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.31
ABPWW 0.0224
ABSI Absci Corporation 2.57
ABUS Arbutus Biopharma Corporation 3.13
ABVC ABVC BioPharma, Inc. 3.57
ABVX Abivax SA American Depositary Shares 8.85
ACAD ACADIA Pharmaceuticals Inc. 22.01
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7624
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.64
ACIU AC Immune SA 2.05
ETFs With Exposure to INM
Ticker ETF Name Weight Percentage Price
YOLO AdvisorShares Pure Cannabis ETF 0.31 2.04
Unlock